Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH3 | Q9Y5N1 | 10/20 | 0.83 |
| ▸ | OPRM1 | P35372 | 9/20 | 0.61 |
| ▸ | OPRD1 | P41143 | 8/20 | 0.61 |
| ▸ | OPRK1 | P41145 | 7/20 | 0.61 |
| ▸ | HRH1 | P35367 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1707159 | 0.91 | HRH3 (1.00) | HRH3OPRM1OPRD1OPRK1HRH1 | |
| SCHEMBL3694962 | 0.84 | OPRM1 (0.69) | HRH3OPRM1OPRD1OPRK1 | |
| SCHEMBL14372315 | 0.84 | HRH3 (0.79) | HRH3HRH1 | |
| SCHEMBL3090975 | 0.82 | HRH3 (0.83) | HRH3HRH1 | |
| SCHEMBL3691940 | 0.81 | OPRM1 (0.86) | HRH3OPRM1OPRD1OPRK1 | |
| SCHEMBL3082047 | 0.81 | HRH3 (0.81) | HRH3HRH1 | |
| SCHEMBL27549464 | 0.81 | OPRM1 (0.69) | HRH3OPRM1OPRD1OPRK1 | |
| SCHEMBL3094776 | 0.80 | HRH3 (0.82) | HRH3HRH1 | |
| SCHEMBL3094821 | 0.80 | HRH3 (0.98) | HRH3HRH1 | |
| SCHEMBL3100997 | 0.80 | HRH3 (1.00) | HRH3HRH1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2208727-A1 | Diaryl ethers as opioid receptor antagonist | Eli Lilly & Company (US) | 2010-07-21 | — | — | EP | disclosed |
| CN-1305852-C | Diaryl ethers as opioid receptor antagonists | LILLY CO ELI (US) | 2007-03-21 | — | — | CN | disclosed |
| CN-1681498-A | Diaryl ethers as opioid receptor antagonist | LILLY CO ELI (US) | 2005-10-12 | — | — | CN | disclosed |